RTX Healthcare Receives FDA 510k Market Clearance For Telehealth Monitor
RTX Healthcare announced a 510k market clearance from the US Food and Drug Administration (FDA) to use the RTX3370 Telehealth Monitor in the US. The Telehealth Monitor is a wireless device designed specifically to improve the provision of healthcare to elderly patients outside hospitals suffering from chronic diseases.

















































